Health in Algeria

1,085 indicators covering health for Algeria.

IndicatorLatest Year10-yr change Rank
Diphtheria tetanus toxoid and pertussis third-dose  (DTP3) 94.0% 2025 down 1.1% 71st
Measles-containing-vaccine first-dose (MCV1) immunization coverage 96.0% 2025 up 1.1% 41st
Hepatitis B (HepB3) immunization coverage among 1-year-olds (%) 94.0% 2025 down 1.1% 70th
Measles-containing-vaccine second-dose (MCV2) immunization coverage 92.0% 2025 down 7.1% 54th
Diphtheria tetanus toxoid and pertussis first-dose (DTP1) 99.0% 2025 unchanged 1st
Implementation of tools to monitor economic and environmental tourism 0 2021 96th
New HIV infections 0.1 2025 unchanged 70th
Stunting prevalence among children under 5 years of age (%) 8.9% 2024 down 20.5% 98th
Stunting numbers among children under 5 years of age (millions) 414.1 2024 down 18.9% 50th
Overweight numbers among children under 5 years of age (thousands) 617 2024 up 5.6% 13th
Overweight prevalence among children under 5 years of age (%) 13.3% 2024 up 3.9% 13th
People using safely managed drinking water services, urban 72.1% 2024 down 10.7% 56th
Mean HDL cholesterol, age-standardized 1.1 2018 unchanged 102nd
Mean total cholesterol, crude 4.3 2018 unchanged 122nd
Mean Non-HDL cholesterol, age-standardized 3.3 2018 down 5.7% 93rd
Mean HDL cholesterol, crude 1.1 2018 unchanged 101st
Mean Non-HDL cholesterol, crude 3.4 2018 down 5.6% 73rd
Mean total cholesterol, age-standardized 4.3 2018 down 2.3% 124th
Prevalence of anemia among children 34.3% 2019 down 2.6% 73rd
Births attended by skilled health staff 98.8% 2019 up 3.8% 75th
Births attended by health staff sdgs 98.8 2019 up 3.8% 75th
Number of deaths among children ages 10 to 14 years 1,140 2021 down 2.2% 54th
Adolescent mortality rate 1.43 2021 down 27.9% 101st
Adults (ages 15+) living with HIV 29,000 2024 up 107.1% 71st
Prevalence of current tobacco use 22.4% 2024 up 5.7% 64th
Prevalence of current tobacco use, females 0.6% 2024 down 33.3% 156th
Prevalence of current tobacco use, males 44.2% 2024 up 6.5% 26th
BCG immunization coverage among 1-year-olds (%) 98.0% 2025 down 1.0% 32nd
Physicians 1.66 per 1,000 people 2022 down 8.7% 96th
Physicians per 1000 people 1.66 2022 down 8.7% 96th
Share of the population infected with hiv 0.0972 2024 up 79.5% 121st
Global vaccination coverage 92 2024 down 3.2% 79th
Proportion of population with primary reliance on clean fuels and 99.0% 2024 up 1.0% 29th
Under-five mortality rate, by sex 21.64 per 1,000 live births 2024 down 14.8% 63rd
Infant mortality rate 19.46 per 1,000 live births 2024 down 12.7% 63rd
Neonatal mortality rate 14.96 per 1,000 live births 2024 down 4.3% 57th
Number of incident tuberculosis cases 25,000 2024 down 19.4% 41st
Incidence of tuberculosis 54 2024 down 32.5% 86th
Number of incident tuberculosis cases 210 2024 down 4.5% 85th
Number of deaths due to tuberculosis, excluding HIV 3,300 2024 down 25.0% 35th
Deaths due to tuberculosis among HIV-negative people 7 2024 down 36.4% 74th
Tuberculosis deaths by hiv status 56 2024 down 11.1% 84th
Tuberculosis case fatality rate 13 2024 down 7.1% 75th
Life satisfaction vs child mortality 5.71 2025 down 10.1% 83rd
Incidence of tuberculosis sdgs 54 2024 down 32.5% 88th
Tuberculosis deaths region 3,300 2024 down 26.7% 44th
Tuberculosis death rate 7.1 2024 down 35.5% 79th
Tuberculosis deaths who 3,300 2024 down 26.7% 44th
People using safely managed sanitation services, rural 56.0% 2024 up 4.1% 39th
Tuberculosis incidence 54 per 100,000 people 2024 down 32.5% 77th
Tuberculosis patients with hiv share 0.83 2024 up 16.9% 143rd
Life expectancy prados de la escosura 74.45 2020 up 0.9% 67th
Prevalence of hiv percentage of males and females ages 15 24 infected 0.1 2024 unchanged 70th
Tuberculosis - new and relapse cases 18,694 2024 down 17.0% 39th
Adults (ages 15+) and children (ages 0-14) newly infected with HIV 2,800 2024 up 115.4% 50th
Tuberculosis treatment coverage 74 2024 up 2.8% 97th
AIDS estimated deaths 500 UNAIDS estimates 2024 unchanged 64th
Mean BMI (kg/m²) 25.5 2016 up 3.2% 116th
Rubella - number of reported cases 5 2024 up 66.7% 65th
Treatment success rate: new TB cases 90 2022 unchanged 43rd